World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-OOB-15005868
Date of registration: 2015-01-22
Prospective Registration: Yes
Primary sponsor: Hong Kong Eye Hospital
Public title: Repeat Collagen Cross-Linking for Keratoconus
Scientific title: Repeat Collagen Cross-Linking for Keratoconus
Date of first enrolment: 2015-02-04
Target sample size: Case series:8;
Recruitment status: Pending
URL:  http://www.chictr.org.cn/showproj.aspx?proj=10312
Study type:  Observational study
Study design:  Case series  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Miss Wong Sin Ting Janice   
Address:  Department of Ophthalmology & Visual Sciences The Chinese University of Hong Kong 3/F Hong Kong Eye Hospital 147K Argyle Street, Mongkok, Hong Kong SAR
Telephone: +852 39435825
Email: janicewong@cuhk.edu.hk
Affiliation:  The Chinese University of Hong Kong
Name: Dr. Chow Wing See Vanissa   
Address:  3/F, Hong Kong Eye Hospital, 147K, Argyle Street, Mongkok, Kowloon, Hong Kong
Telephone: +852 39435825
Email: vanissa.chow@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Previously treated with accelerated CXL;
2. Progressive keratoconus after treatment, as defined by
(1) worsened best-corrected visual acuity not accountable by corneal scarring (or other lenticular or posterior segment diseases), and/or
(2) 1D increase in steepest curvature, >1D increase in manifest cylinder and >0.5D increase in manifest spherical equivalent observed at two consecutive occasions.

Exclusion criteria: 1. Central ECD less than at least 2000;
2. Corneal pachymetry <400um at thinnest point (on Pentacam);
3. Corneal scarring;
4. History of corneal surgery, herpetic eye disease, severe DES, LSCD, delayed epithelial healing;
5. Underlying autoimmune disease, pregnancy, nursing.


Age minimum: 13
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Keratoconus
Intervention(s)
Case series:1. UV-A 3mW : 30 minutes; 2. 1% riboflavin: q2min x 15;
Primary Outcome(s)
Topography: Kmax, Kmean, anterior elevation, posterior elevation;
Secondary Outcome(s)
1. Visual acuity;2. Refraction;3. Endothelial cell density;4. Axial length;5. Pachymetry;6. Complications;
Secondary ID(s)
CUHK_CCT00444
Source(s) of Monetary Support
Hong Kong Eye Hospital
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history